The Trustees of Columbia University in the City of New York
发明人:
LENTZSCH, Suzanne
申请号：
AU2018311688
公开号：
AU2018311688A1
申请日:
2018.07.24
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
Methods and pharmaceutical compositions for treatment of amyloid deposition diseases using chimeric (e.g., mouse-human) antibody are disclosed, including a method for treating amyloid deposition diseases with cardiac involvement by administering pharmaceutical compositions comprising a chimeric anti-amyloid fibril antibody. The methods herein can improve myocardial function in patients diagnosed with light chain amyloid light chain amyloidosis (ALA) having a cardiac involvement in as little as three weeks after treatment.
